Hochmair, M. J., Buder, A., Schwab, S., Burghuber, O. C., Prosch, H., Hilbe, W., . . . Filipits, M. (2018). Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib. Target Oncol.
Citação norma ChicagoHochmair, Maximilian J., Anna Buder, Sophia Schwab, Otto C. Burghuber, Helmut Prosch, Wolfgang Hilbe, Agnieszka Cseh, Richard Fritz, and Martin Filipits. "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients With Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib." Target Oncol 2018.
Deismireacht MLAHochmair, Maximilian J., et al. "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients With Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib." Target Oncol 2018.